BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31858231)

  • 21. Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study.
    Zerbi A; Capitanio V; Boninsegna L; Delle Fave G; Pasquali C; Rindi G; Campana D; Falconi M;
    HPB (Oxford); 2013 Dec; 15(12):935-43. PubMed ID: 23472667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms.
    Gao Y; Gao H; Wang G; Yin L; Xu W; Peng Y; Wu J; Jiang K; Miao Y
    Sci Rep; 2018 May; 8(1):7271. PubMed ID: 29739948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.
    Sadula A; Li G; Xiu D; Ye C; Ren S; Guo X; Yuan C
    Comput Math Methods Med; 2022; 2022():3689895. PubMed ID: 35720036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic Neuroendocrine Neoplasms Larger than 4 cm: A Retrospective Observational Study of Surgery, Histology, and Outcome.
    Milanetto AC; Gais Zürcher AL; David A; Fassan M; Pasquali C
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconsideration of operative indications in pancreatic neuroendocrine neoplasms.
    Abe K; Kitago M; Iwasaki E; Yagi H; Abe Y; Hasegawa Y; Hori S; Tanaka M; Nakano Y; Kitagawa Y
    World J Surg Oncol; 2022 Nov; 20(1):366. PubMed ID: 36397094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.
    Nomura N; Fujii T; Kanazumi N; Takeda S; Nomoto S; Kasuya H; Sugimoto H; Yamada S; Nakao A
    J Hepatobiliary Pancreat Surg; 2009; 16(5):639-47. PubMed ID: 19365596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node metastases and recurrence in pancreatic neuroendocrine neoplasms.
    Nießen A; Schimmack S; Lewosinska M; Hinz U; Bechtiger FA; Hackert T; Büchler MW; Strobel O
    Surgery; 2022 Dec; 172(6):1791-1799. PubMed ID: 36180252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
    Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.
    Yamamoto Y; Okamura Y; Uemura S; Sugiura T; Ito T; Ashida R; Kato Y; Ohgi K; Yamada M; Sasaki K; Aramaki T; Uesaka K
    Ann Surg Oncol; 2017 Aug; 24(8):2363-2370. PubMed ID: 28271173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumors.
    Reinhard L; Mogl MT; Benz F; Dukaczewska A; Butz F; Dobrindt EM; Tacke F; Pratschke J; Goretzki PE; Jann H
    Langenbecks Arch Surg; 2023 Jun; 408(1):237. PubMed ID: 37332044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.
    Lopez CL; Waldmann J; Fendrich V; Langer P; Kann PH; Bartsch DK
    Langenbecks Arch Surg; 2011 Dec; 396(8):1187-96. PubMed ID: 21805182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
    Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
    Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades.
    Jin F; Wang K; Qin TT; Li X; Guo F; Ma GN; Hu XH; Han P
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):587-595. PubMed ID: 28786064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodality management, recurrence patterns, and long-term outcome of gastroenteropancreatic neuroendocrine neoplasms: Progress over 17 years.
    Desai GS; Pande P; Chhabra V; Shah RC; Jagannath P
    Indian J Gastroenterol; 2019 Oct; 38(5):399-410. PubMed ID: 31802438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
    Sallinen V; Haglund C; Seppänen H
    Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
    Martin-Perez E; Capdevila J; Castellano D; Jimenez-Fonseca P; Salazar R; Beguiristain-Gomez A; Alonso-Orduña V; Martinez Del Prado P; Villabona-Artero C; Diaz-Perez JA; Monleon A; Marazuela M; Pachon V; Sastre-Valera J; Sevilla I; Castaño A; Garcia-Carbonero R
    Neuroendocrinology; 2013; 98(2):156-68. PubMed ID: 23988576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.